Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
- Peter Schmid
- , Javier Cortes
- , Rebecca Dent
- , Heather Mcarthur
- , Lajos Pusztai
- , Sherko Kümmel
- , Carsten Denkert
- , Yeon Hee Park
- , Rina Hui
- , Nadia Harbeck
- , Masato Takahashi
- , Seock Ah Im
- , Michael Untch
- , Peter A. Fasching
- , Marie Ange Mouret-Reynier
- , Theodoros Foukakis
- , Marta Ferreira
- , Fatima Cardoso
- , Xuan Zhou
- , Vassiliki Karantza
- Queen Mary University of London
- Pangaea Oncology, S.A.
- Universidad Europea
- Duke-NUS Medical School
- Southwestern Medical Center
- Yale University
- Kliniken Essen-Mitte
- Charité – Universitätsmedizin Berlin
- University of Marburg
- Fresenius AG
- The University of Sydney
- The University of Hong Kong
- Ludwig Maximilian University of Munich
- Hokkaido University
- Seoul National University
- Friedrich-Alexander University Erlangen-Nürnberg
- Centre Jean Perrin
- Karolinska Institutet
- Instituto Português de Oncologia do Porto Francisco Gentil E.P.E.
- Champalimaud Clinical Center/Champalimaud Foundation
- Merck
- Baylor Health Care System
Research output: Contribution to journal › Article › peer-review
472
Link opens in a new tab
Scopus
citations